Design Mark 90426944

Registered
Design Mark

Key Information

Serial Number

Registration Number

Status

Registered

Ownership

PI

Owner Name

Type: Organization / Corporation

Address

66 Hudson Boulevard East
New York, NY 100012192

Critical Dates

First Use Date

Aug 31, 2023

Filing Date

Dec 29, 2020

Registration Date

Jan 7, 2025

Mark Descriptions

Goods

Class 5
Pharmaceutical preparations for the treatment of endocrine diseases and disorders, namely, human growth hormones

Mark Elements

Text Mark
Design Mark 90426944
Category
Trademark
Standard Characters
No
Color Claim
No
Design Search Codes
24.17.15
Check marks
26.17.09
Bands, curved
26.17.12
Angles (geometric)
Data source: USPTO TSDR
View on USPTO website

Trademark Timeline

First Use

Aug 31, 2023

Filing Date

Dec 29, 2020

Publication Date

Jul 20, 2021

Registration Date

Jan 7, 2025

USPTO Records

TitleDateCategorySourcePagesFormatActions

AI AssessmentCached Mar 12, 2026, 06:40 AM
Cached

AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.

Trademark Summary

The design mark (image file 90426944.jpg) features check marks, curved bands or bars, and chevrons, with no color claimed, and covers pharmaceutical preparations for the treatment of endocrine diseases and disorders, namely, human growth hormones in International Class 005 (active), along with goods/services in classes 006, 018, 044, 046, 051, and 052. It is owned by Pfizer Inc., a Delaware corporation headquartered at 66 Hudson Boulevard East, New York, New York. The mark is registered on the Principal Register as of January 7, 2025 (Registration No. 7644695), with first use and use in commerce as of August 31, 2023, and no active legal proceedings or notable issues.

Recent Activity

Filed on December 29, 2020, the application was published for opposition on July 20, 2021, followed by a notice of allowance on September 14, 2021. After five extensions of time to file a statement of use, the statement was received and accepted in August and December 2024, leading to registration on January 7, 2025; attorney and correspondence updates occurred on January 30, 2026.
USPTO
AI Analysis
v2.8.0
Generated Mar 12, 2026, 06:40 AM

Never miss important updates for this trademark

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.